Citation Information :
Lal R, Baronia AK, Naranje KM, Bhriguvanshi A, Singh RK. Blood Glucose Variability and Outcomes in Critically III Children. Indian J Crit Care Med 2017; 21 (3):122-126.
Objectives: To find the incidence of hyperglycemia (blood glucose [BG] ≥150 mg/dl), hypoglycemia (BG ≤60 mg/dl), and variability (presence of hypoglycemia and hyperglycemia) in critically ill children in the 1st week of Intensive Care Unit (ICU) stay and their association with mortality, length of ICU stay, and organ dysfunction.
Materials and Methods: The design was a retrospective observational cohort study. Consecutive children ≤18 years of age admitted from March 2003 to April 2012 in a combined adult and pediatric closed ICU. Relevant data were collected from chart review and hospital database.
Results: Out of 258 patients included, isolated hyperglycemia was seen in 139 (53.9%) and was unrelated to mortality and morbidity. Isolated variability in BG was noted in 76 (29.5%) patients and hypoglycemia was seen in 9 (3.5%) patients. BG variability was independently associated with multiorgan dysfunction syndrome on multivariate analysis (adjusted odds ratio [OR]: 7.1; 95% confidence interval [CI]: 1.6–31.1). Those with BG variability had longer ICU stay (11 days vs. 4 days, on log-rank test, P = 0.001). Insulin use was associated with the occurrence of variability (adjusted OR: 3.6; 95% CI: 1.8–7.0).
Conclusion: Glucose disorders were frequently observed in critically ill children. BG variability was associated with multiorgan dysfunction and increased ICU stay.
Lodha R, Bhutia TD, Kabra SK, Thukral A. Day 1 blood glucose and outcome in critically ill children. Indian Pediatr 2009;46:809-10.
Faustino EV, Bogue CW. Relationship between hypoglycemia and mortality in critically ill children. Pediatr Crit Care Med 2010;11:690-8.
Faustino EV, Hirshberg EL, Bogue CW. Hypoglycemia in critically ill children. J Diabetes Sci Technol 2012;6:48-57.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with Intensive Care Unit mortality in critically ill children. Pediatr Crit Care Med 2004;5:329-36.
Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005;146:30-4.
Mikos B, Barkai L. Hyperglycemia and mortality in critically ill children. Orv Hetil 2007;148:683-8.
Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric Intensive Care Unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008;9:361-6.
Wintergerst KA, Foster MB, Sullivan JE, Woods CR. Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric Intensive Care Unit. J Diabetes Sci Technol 2012;6:5-14.
Bhutia TD, Lodha R, Kabra SK. Abnormalities in glucose homeostasis in critically ill children. Pediatr Crit Care Med 2013;14:e16-25.
Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012;367:1208-19.
Macrae D, Grieve R, Allen E, Sadique Z, Morris K, Pappachan J, et al. A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med 2014;370:107-18.
Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-52.
Ali NA, O'Brien JM Jr., Dungan K, Phillips G, Marsh CB, Lemeshow S, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008;36:2316-21.
Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Glucose variability; does it matter? Endocr Rev 2010;31:171-82.
Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric Intensive Care Unit. Pediatrics 2006;118:173-9.
Patki VK, Chougule SB. Hyperglycemia in critically ill children. Indian J Crit Care Med 2014;18:8-13.
Yung M, Wilkins B, Norton L, Slater A; Paediatric Study Group; Australian and New Zealand Intensive Care Society. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 2008;9:147-52.
Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: Risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr 2009;155:734-9.
Yates AR, Dyke PC 2nd, Taeed R, Hoffman TM, Hayes J, Feltes TF, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006;7:351-5.
Klein GW, Hojsak JM, Schmeidler J, Rapaport R. Hyperglycemia and outcome in the pediatric Intensive Care Unit. J Pediatr 2008;153:379-84.
Rake AJ, Srinivasan V, Nadkarni V, Kaptan R, Newth CJ. Glucose variability and survival in critically ill children: Allostasis or harm? Pediatr Crit Care Med 2010;11:707-12.
Preissig CM, Hansen I, Roerig PL, Rigby MR. A protocolized approach to identify and manage hyperglycemia in a pediatric Critical Care Unit. Pediatr Crit Care Med 2008;9:581-8.
Garcia Branco R, Tasker RC, Ramos Garcia PC, Piva JP, Dias Xavier L. Glycemic control and insulin therapy in sepsis and critical illness. J Pediatr (Rio J) 2007;83 5 Suppl: S128-36.
Faraon-Pogaceanu C, Banasiak KJ, Hirshberg EL, Faustino EV. Comparison of the effectiveness and safety of two insulin infusion protocols in the management of hyperglycemia in critically ill children. Pediatr Crit Care Med 2010;11:741-9.
